Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 3 16Phase 1 16Phase 4 13Phase EARLY_PHASE1 4Phase 1/2 4Phase 2/3 2Phase NA 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Imiquimod × Clear all
NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed
22 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00941252 2011-01-24

ITIC

Medical University of Vienna

Phase 2/3 Completed
60 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡